Home Newsfeeds UBS Maintains Neutral on Netflix, Raises Price Target to $250

UBS Maintains Neutral on Netflix, Raises Price Target to $250

UBS analyst John Hodulik maintains Netflix (NASDAQ:NFLX) with a Neutral and raises the price target from $198 to $250.

byBenzinga Newsdesk

October 14, 2022

1 minute read

UBS analyst John Hodulik maintains Netflix (NASDAQ:NFLX) with a Neutral and raises the price target from $198 to $250.

Cowboy Ventures Partner Prescribes Ozempic Diet For Startups: ‘Do More With Less’

By Benzinga Newsbot

June 27, 9:13 PM

Startups may be entering the “age of Ozempic,” according to Aileen Lee, partner at Cowboy Ventures. Lee made…

NVO

$130B Asset Manager Hightower Makes Splash With $68M Spot Bitcoin ETF Purchase

By Murtuza Merchant

May 7, 8:51 AM

Hightower Advisors, a leading $130 billion asset management firm, has purchased $68 million worth of spot Bitcoin ETFs, according to a recent 13F SEC filing.

BTC

Crude Oil Moves Lower; Micron Issues Strong Forecast

By Avi Kapoor

December 21, 12:59 PM

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Thursday. The Dow traded up 0.58% to 37,296.40 while the NASDAQ rose 0.77% to 14,891.87. The S&P 500 also rose, gaining, 0.68% to 4,730.26.

CLNN

Analyst Ratings

4 Analysts Have This to Say About Laboratory Corp

By Benzinga Insights

November 23, 11:01 AM

Over the past 3 months, 4 analysts have published their opinion on Laboratory Corp (NYSE:LH) stock. These analysts…

UBS Maintains Neutral on Netflix, Raises Price Target to $250

Related Posts

Cowboy Ventures Partner Prescribes Ozempic Diet For Startups: ‘Do More With Less’

$130B Asset Manager Hightower Makes Splash With $68M Spot Bitcoin ETF Purchase

Crude Oil Moves Lower; Micron Issues Strong Forecast

4 Analysts Have This to Say About Laboratory Corp